Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-X-L inhibitor ABT-263 in KRAS-mutant colorectal cancers
- Issued Date
- 2021
- Type
- Article
- Publisher
- CANCER LETTERS
- Language
- 영어
- ISSN
- 0304-3835
- Citation Volume
- 497
- Citation Start Page
- 123
- Citation End Page
- 136
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.